Total Intravenous Anesthesia and Recurrence Free Survival
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The investigators propose to compare recurrence-free survival in patients having potentially
curative (Stages 1-3) surgery for esophageal cancer who will be randomly assigned to
propofol-based total intravenous anesthesia or sevoflurane-based balanced general anesthesia.